News
Frost & Sullivan: New Drug Candidates Hold Tremendous Promise for...
www.finanznachrichten.de
- Patients to benefit from potential for improved efficacy in less commonly used types of ARV therapies and one-pill-daily combination drugs LONDON, April...
CROs Offer Promise of Safe and Effective Drug Development Labmate...
www.labmate-online.com
… and biotech companies are outsourcing research in order to develop innovative products that meet the rising demand for the…utics across a...
European monoclonal antibody market set to hit $42bn by PMLiVE
www.pmlive.com
· Frost & Sullivan research analyst Deepika Pramod Chopda said: “Technological development within the biotech and genomic markets triggered ...
Latest News - Cypriot Biotech Database
www.cypriotbiotech.com
... new drug candidates over the last decade have spurred the HIV drugs market," notes Frost & Sullivan Healthcare Research Analyst Deepika Pramod Chopda.
sortiert nach Relevanz / Datum